![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion
10 juin 2013 02h10 HE
|
Pearl Therapeutics
Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics
Inc. today announced that it has entered into a definitive
merger agreement under which the Company will be acquired...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting
17 mai 2013 08h00 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF, May 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the Company would
be presenting four posters at the upcoming annual meeting of the
American Thoracic...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Initiates PT003 Phase 3 Program for the Treatment of Individuals with Moderate-to-Severe COPD
13 mai 2013 17h28 HE
|
Pearl Therapeutics
Redwood City, CA, May 13, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced the initiation of
PINNACLE, a global Phase 3 program of PT003, the Company's
fixed-dose combination of...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology
14 mars 2013 08h00 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF, March 14, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced their receipt of the
2013 Drug Delivery Partnerships™ (DDP) Innovation Award for the
Company's...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Strengthens its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development
17 janv. 2013 08h00 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF, Jan. 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that Michael
Riebe, Ph.D. has joined Pearl Therapeutics as vice president,
pharmaceutical development and...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics to Present at J.P. Morgan Healthcare Conference
04 janv. 2013 08h00 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF, Jan. 4, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that Chuck
Bramlage, the Company's president and CEO will be providing a
corporate and clinical update at...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Issued U.S. Patent on Co-Suspension Formulation Technology
05 déc. 2012 08h00 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the U.S. Patent and
Trademark Office has issued a patent on its novel co-suspension
formulation...
![Pearl Therapeutics Logo](/news-release/logo/233262/0/233262.jpg?lastModified=12%2F09%2F2016%2023%3A10%3A23&size=2)
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
13 nov. 2012 07h30 HE
|
Pearl Therapeutics
REDWOOD CITY, CALIF, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced a $65 million
Series D financing raised from current investors. 5AM
Ventures, Clarus Ventures and...